Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2868543/0/en/Oruka-Therapeutics-Expands-Leadership-Team-Naming-Joana-Goncalves-MBChB-as-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2024/04/02/2855780/29236/en/Cara-Therapeutics-to-Present-at-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/03/07/2842091/29236/en/Cara-Therapeutics-to-Host-Notalgia-Paresthetica-NP-Virtual-KOL-Event-on-Wednesday-March-27-2024.html
https://www.globenewswire.com//news-release/2024/03/04/2839952/29236/en/Cara-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/12/2827845/29236/en/Cara-Therapeutics-to-Announce-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-March-4-2024.html
https://www.fiercebiotech.com/biotech/itch-treater-cara-cuts-50-team-extend-runway-2026
https://www.globenewswire.com//news-release/2024/01/22/2812893/29236/en/Cara-Therapeutics-Prioritizes-Late-Stage-Notalgia-Paresthetica-Program-and-Extends-Cash-Runway-into-2026.html
https://www.globenewswire.com//news-release/2023/12/18/2797670/29236/en/Cara-Therapeutics-Announces-Outcome-from-Dose-Finding-Part-A-of-KIND-1-Study-Evaluating-Oral-Difelikefalin-for-Moderate-to-Severe-Pruritus-in-Patients-with-Atopic-Dermatitis.html
https://www.globenewswire.com//news-release/2023/11/13/2779412/29236/en/Cara-Therapeutics-Reports-Third-Quarter-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2023/11/02/2772132/29236/en/Cara-Therapeutics-Announces-up-to-40-0-Million-Non-Dilutive-Financing-Agreement-with-HealthCare-Royalty.html